Searched for
PFIZER IAN READ
How safe is it to switch and space COVID-19 vaccine doses?Faced with surging pandemic and new, more transmissible coronavirus variants, some countries are hoping to broaden immunisation by giving s...- Mylan deal to give a boost to Pfizer’s India business: AnalystsOn Monday, Pfizer and Mylan announced that as per the Reverse Morris Trust transaction, each Mylan share would be converted into one share ...
- Pfizer replaces longtime CEO Read with veteran BourlaRead, who was appointed CEO in December 2010, will become the executive chairman of Pfizer's board from Jan. 1.
- Pfizer reviewing alternatives for consumer healthcare businessPfizer consumer healthcare develops, manufactures and markets leading non-prescription medicines, vitamins, and personal care products.
- Pfizer surges 5% as parent acquires Medivation in $14 bn dealThe US-based company said the acquisition would be immediately accretive to adjusted diluted EPS upon closing of the deal.
- Pfizer to buy Allergan in $160 billion deal to create world's No 1 drugmakerNew York-based Pfizer and Allergan, headquartered in Ireland, said on Monday that Pfizer would offer 11.3 of its own shares for each Allerg...
- Pfizer buying Hospira for about $15.23 billionPfizer is buying Hospira for approximately $15.23 billion, saying it is a good fit with its global established pharmaceutical business.
- AstraZeneca rejects 55 pounds/share Pfizer offerBritain's AstraZeneca on Monday rejected a sweetened 55-pounds-a-share offer from Pfizer.
- Pfizer move on AstraZeneca threatens UK science, lawmakers sayPfizer's potential takeover of AstraZeneca poses a threat to British science unless it can give more concrete, enforceable guarantees on jo...
- Pfizer pledges to ringfence drug development in AstraZeneca dealAstraZeneca said on Tuesday that Pfizer's proposal risked disrupting its research and delaying getting life-saving new drugs to market.
- AstraZeneca deal: Pfizer chief Ian Read says jobs will go in takeoverPfizer Inc.'s chief executive acknowledged Tuesday that a potential merger with AstraZeneca would lead to job losses _ but promised to keep...
- Pfizer boss enters lion's den of UK politics to sell AstraZeneca dealIn Tuesday's sessions lawmakers will also interrogate AstraZeneca's French CEO Pascal Soriot and business minister Vince Cable.
- Pfizer to internally split its generic, branded drugs operationsPharma giant Pfizer Inc today said it plans to internally separate operations into three segments.
- Pfizer to buy back $10 b in stock in line with its repurchase strategyThis is the fourth major share repurchase programme for New York-based company in past two-and-a-half years.
- Pfizer posts Q3 profit fall, lowers outlookPfizer lowered its outlook for 2012 after a tough third quarter hit by the loss of exclusivity on its blockbuster Lipitor.
- Pfizer fights to retain Lipitor market shareThe move is expected to hit Ranbaxy Pharma, which has the exclusive rights to sell the generic version for three months beginning November ...
- Pfizer 4Q profit beats views as revenue up 6 pcPfizer Inc.'s new CEO on Tuesday outlined plans to reduce the company's spending and work force and focus more sharply on promising drugs a...
- Read succeeds Kindler as Pfizer CEOIan C Read has been appointed as President and Chief Executive Officer (CEO) of Pfizer Inc, the US-based drug maker, succeeding Jeffrey B K...
- Pfizer awards bonuses to executives for Wyeth dealChief Financial Officer Frank D'Amelio will receive a $1.2 million award and Ian Read, group president of Pfizer's biopharmaceutical busine...
- Ranbaxy, Pfizer sign truce over LipitorRanbaxy has settled most of its patent disputes with Pfizer, allowing it to launch a generic version of Lipitor from November 30, 2011. Ran...
Load More
